Society

17 health care workers in Japan suffer anaphylaxis after vaccination

Mar 10 (Japan Today) - People in Japan who received Pfizer Inc's COVID-19 vaccine seem to have suffered anaphylaxis at a higher rate than in the United States and Europe, the minister in charge of vaccination efforts said Wednesday.

Taro Kono told a Diet committee that 17 cases of anaphylaxis, a severe and potentially fatal allergic reaction, have been reported among the 107,558 health care workers who had been inoculated as of Tuesday.

"It's true, this seems to be more than in the United States and Europe," he said.

The rate compares with five cases in every one million doses administered in the United States and 20 cases per million in Britain, though Japan is further behind in its vaccine rollout and it could change as more people receive shots.

Japan is in the process of inoculating some 4.8 million health care workers nationwide before expanding to people aged 65 or older in mid-April. People with pre-existing conditions such as diabetes, and those working at elderly care facilities are slated to come next.

People who take the COVID-19 vaccine developed by Pfizer and its partner BioNTech SE are being asked to remain on site for at least 15 minutes to check for anaphylaxis and other side effects.

According to the Ministry of Health, Labor and Welfare, symptoms experienced within five to 30 minutes of receiving a shot include sore throat, hives and difficulty breathing. All of them recovered after receiving treatment.

Health minister Norihisa Tamura has said a ministry panel plans to review the matter on Friday, looking into whether the symptoms reported in Japan were as serious as those abroad.

Pfizer has said clinical trials showed its vaccine to be 95 percent effective in preventing symptoms of COVID-19, and Prime Minister Yoshihide Suga has called inoculations the "decisive factor" in bringing the pandemic under control.

But only 63.1 percent of respondents in a Kyodo News poll conducted last month said they want to be vaccinated, with 27.4 percent saying they do not, apparently due to concerns over side effects.

Student's Homemade Bomb Sparks School Lockdown in Sapporo

A suspicious object feared to be explosive was discovered at a high school in Sapporo on the afternoon of November 22nd, causing temporary chaos. The object was found to have been brought to the school by one of its students.

China to resume visa-exemptions for short-term Japanese travelers

China says it will resume allowing visa-free visits by Japanese nationals on short-term trips from the end of this month. (NHK)

Japan Grapples with Poverty and Rising 'Invisible Homeless'

Japan is facing a deepening crisis of poverty and inequality, with rising reports of 'invisible homeless' individuals and growing economic hardships among the population. Discussions over reforms to the country's tax and welfare systems have taken center stage, as policymakers grapple with how to provide meaningful support.

Ueno Toshogu Shrine Shines in Gold with Special Lighting

A special lighting ceremony was held on November 20th at Ueno Toshogu Shrine, located in Ueno Park, Taito Ward, Tokyo. The event featured a unique lighting design created by renowned lighting designer Motoko Ishii.

World's First Fiber Made From Bagworm Silk Revolutionizes Industry

A Japanese pharmaceutical company has announced the successful commercialization of fiber made from silk produced by bagworms.

MEDIA CHANNELS

MORE Society NEWS

Man With Snake Tattoo Accused of Theft and Headbutting Store Employee

A man with a distinctive snake-like tattoo on his face has been arrested for shoplifting and assaulting a convenience store employee in Tokyo. The suspect, identified as 49-year-old Masakatsu Echizenya, is accused of stealing items from a store around noon on November 15th and violently attacking the employee who confronted him.